Our Latest Thinking

We are constantly scanning the health care market for new and interesting developments; then we write about them here. Check out our latest thinking.

2018 Midterm Elections: Implications for Health Policy in the United States
November 14, 2018

The midterm elections present the opportunity to reset the health policy agenda in Congress and in states across the country. On November 14, 2018, Leavitt Partners’ team of experts talked through the policy agendas for the incoming majority and minority parties in the next Congress. We also discussed changes that could potentially impact states across […]

Read More >
Preventing Chronic Disease in the Rising-Risk Population: Three Strategies for ACOs Before, During, and After the Patient Engages in the Clinical Care Setting
November 13, 2018

In this paper, “Preventing Chronic Disease in the Rising-Risk Population: Three Strategies for ACOs Before, During, and After the Patient Engages in the Clinical Care Setting,” the American Medical Association (AMA) and Leavitt Partners offer strategies for health care organizations working within an alternative payment model to target the rising-risk population. These recommendations include: Identifying […]

Read More >
Addiction Recovery Medical Home – Alternative Payment Model
October 31, 2018

The United States is in the middle of a major public health challenge: since 1999, the rate of overdoses involving opioids nearly quadrupled. As startling as this number is, before, and during this period alcohol-related deaths still out-paced opioids. Addiction has now become the leading cause of death in America for those under 50. Substance […]

Read More >
Paying for Poor Choices
October 23, 2018

Early this year former Treasury Secretary Larry Summers made a case for taxing sugary drinks and cigarettes to deter individuals from consuming products that lead to obesity and chronic disease. Taxing such products could gain importance as policy makers consider comprehensive coverage policies such as “Medicare for all.” The reason is based both on principle […]

Read More >
Examining Pessimism Among Physicians: 2017 Survey on Physicians’ Outlook on the Practice of Medicine
October 18, 2018

Physician satisfaction is an important component in the effort to improve health care access and quality and reduce costs. In a nationwide survey of 621 physicians, we found that 38 percent of physicians reported having a pessimistic outlook on the practice of medicine today. In this study, we identified physician characteristics that are correlated with […]

Read More >
Leavitt Partners Releases “Examining Pessimism Among Physicians: 2017 Survey on Physicians’ Outlook on the Practice of Medicine” White Paper
October 18, 2018

Salt Lake City, October 18, 2018 –Today, Leavitt Partners released “Examining Pessimism Among Physicians: 2017 Survey on Physicians’ Outlook on the Practice of Medicine,” a white paper that investigates associations between certain physician characteristics and a pessimistic outlook on the practice of medicine. The paper discusses findings from a national survey of 621 physicians. Leavitt […]

Read More >
Medicaid Closed Drug Formularies: A Closed Door or a Path Forward?
October 2, 2018

As we noted in July, CMS declined Massachusetts’ Medicaid 1115 demonstration request to establish a closed formulary.  The proposed program would have given Massachusetts the ability to exclude certain FDA-approved drugs from coverage and thereby given the state additional leverage in negotiating rebates.  The state and drug manufacturers would have otherwise continued to be subject […]

Read More >
Leavitt Partners Releases “Evaluating the Performance of State Individual Markets Using the Individual Market Effectiveness Index” White Paper
September 27, 2018

Salt Lake City, September 27, 2018 –Today, Leavitt Partners released “Evaluating the Performance of State Individual Markets Using the Individual Market Effectiveness Index,” a white paper that provides a more evidence-based approach for evaluating the performance of each state’s individual market. Since the Affordable Care Act’s passage, health care stakeholders, politicians, and consumers have scrutinized […]

Read More >